Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,624 | -121 | 205 | -325 | -320 |
| Depreciation Amortization | 220 | 131 | 114 | 105 | 105 |
| Other Working Capital | -409 | 508 | 510 | 423 | 229 |
| Other Operating Activity | -59 | -913 | -1,029 | -307 | -79 |
| Operating Cash Flow | $-1,872 | $-396 | $-200 | $-104 | $-65 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -333 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-333 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,274 | 37 | 37 | N/A | N/A |
| Debt Repayment | -605 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 324 | 296 | N/A | N/A |
| Financing Cash Flow | $3,670 | $361 | $333 | $N/A | $N/A |
| Exchange Rate Effect | -18 | -13 | 5 | 1 | -1 |
| Beginning Cash Position | 65 | 112 | 112 | 112 | 112 |
| End Cash Position | 1,511 | 65 | 250 | 10 | 47 |
| Net Cash Flow | $1,446 | $-48 | $138 | $-103 | $-66 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,872 | -396 | -200 | -104 | -65 |
| Free Cash Flow | -1,872 | -396 | -200 | -104 | -65 |